Transaction · 0001610717-26-000360

BIENAIME JEAN JACQUES

BIENAIME JEAN JACQUES, DIR, reported an open-market or private purchase at Ascendis Pharma A/S involving 1100.000000 shares for an estimated $270435.00. Reported holdings after the transaction were 2000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR
ASNDAscendis Pharma A/S
Filing timeAug 19
Trade dateAug 14, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$259.62
Pre-filing
1mo ago +3.4%1w ago -1.6%1d ago -5.2%
Returns since
7d -3.6%30d +0.2%90d +0.2%180d +0.2%1y +0.2%

ASND price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ASND since 2026-08-19Filed 16 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001610717-26-000360
Ordinary Shares
Transaction date
Aug 14, 2026
Filed Aug 19, 2026, 01:02 AM · 5d delay
Shares
1.10k sh
$24.5k per share
Estimated value
$27.0M
Computed from shares × price
Holdings after
2.00k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Director Buy Direct Ownership Large Holdings Increase
+32score
Filing-only score

+32

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $245.41 to $246.30 inclusive. The Reporting Person undertakes to…

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $246.48 to $247.32 inclusive. The Reporting Person undertakes to…

Original filing · 0001610717-26-000360
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ASND